Clinical Use of Natriuretic Peptides:

Proceedings of Singapore Healthcare

Clementine YFYap¹ 

关键词: Acute heart failure;    B-type natriuretic peptide;    Congestive heart failure;    Dyspnea;    N-terminal-proBNP;   

DOI  :  10.1177/201010581102000410

学科分类：医学（综合）

来源: Sage Journals

【 摘 要 】

Either B-type natriuretic peptide (BNP) or NT-proBNP may be used as a diagnostic, screening, prognostic and therapeutic tool for CHF. The Food and Drug Administration (FDA) cleared the cut-off point for BNP at 100 pg/mL, and that of NT-proBNP at 125 pg/mL for patients <75 years and 450 pg/mL for those >75. A steadily rising titre even below the cut-off value should be raised as a concern as heart failure is progressive if left untreated and may result in cardiac death. Both biomarkers are also featured in lab investigations for patients with acute coronary syndrome (ACS).

【 授权许可】

CC BY